Skip to main content
PYPD
NASDAQ Life Sciences

PolyPid Posts Zero Revenue and Wider-Than-Expected Loss in Q3

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$6.219
Mkt Cap
$128.167M
52W Low
$3.5
52W High
$6.68
52W Position info
78% above low
Off High info
6.9% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

PYPD sits 78% above its 52-week low of $3.5.

Summary

PolyPid reported a Q3 adjusted loss of 24 cents a share, missing the 6 cents of earnings five analysts expected, and revenue came in at zero versus an $18.00 million consensus. The quarterly net loss was $5.75 million. The miss is stark but not a surprise in kind: the company has no approved product revenue yet, and the story remains the D-PLEX100 EU marketing application now under EMA review after the October 1 validation, plus the November 28, 2026 PDUFA date for the U.S. filing. The October 1 mutual termination of the ADVANZ PHARMA European license returned commercialization rights to PolyPid, so the company is now carrying that launch burden itself. Shares are up 45.4% year to date and 19.7% this quarter, so the gap between zero revenue and a $12 median price target leaves little room for execution slippage.

At the time of this announcement, PYPD was trading at $6.22 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $128.2M. The 52-week trading range was $3.50 to $6.68. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

PYPD - Latest Insights

PYPD
Oct 28, 2026, 8:03 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $5.75
Real-time Price: $6.74 info
Change: +$0.990 (+17%) info
Market Cap: $136.901M info
PYPD
Oct 01, 2026, 9:20 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $5.30
Real-time Price: $6.74 info
Change: +$1.44 (+27%) info
Market Cap: $136.901M info
PYPD
Oct 01, 2026, 8:56 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.27
Real-time Price: $6.74 info
Change: +$1.47 (+28%) info
Market Cap: $136.901M info
PYPD
Aug 12, 2026, 4:58 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $4.80
Real-time Price: $6.74 info
Change: +$1.94 (+40%) info
Market Cap: $136.901M info
PYPD
Aug 12, 2026, 7:35 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $4.35
Real-time Price: $6.74 info
Change: +$2.39 (+55%) info
Market Cap: $136.901M info